Literature DB >> 18962898

Short leucine-rich glycoproteins of the extracellular matrix display diverse patterns of complement interaction and activation.

Andreas P Sjöberg1, Gavin A Manderson, Matthias Mörgelin, Anthony J Day, Dick Heinegård, Anna M Blom.   

Abstract

The extracellular matrix consists of structural macromolecules and other proteins with regulatory functions. An important family of the latter class of molecules found in most tissues is the small leucine-rich repeat proteins (SLRPs). We have previously shown that the SLRP fibromodulin binds directly to C1q and activates the classical pathway of complement. In the present study we further examine the interactions between SLRPs and complement. Osteoadherin, like fibromodulin, binds C1q and activates the classical pathway strongly while moderate activation is seen in the terminal pathway. This can be explained by the interaction of fibromodulin and osteoadherin with factor H, a major soluble inhibitor of complement. Also, chondroadherin was found to bind C1q and activate complement, albeit to a lesser extent. Chondroadherin also binds factor H. We confirm published data showing that biglycan and decorin bind C1q but do not activate complement. In this study a similar pattern is seen for lumican although its affinity for C1q is lower than for biglycan and decorin. Furthermore, using electron microscopy and radiolabeled SLRPs, we demonstrate two different classes of SLRP binding sites on C1q, to head and stalk respectively, where only binding to the head appears to be activating. We propose a role for SLRPs in the regulation of complement activation in diseases involving the extracellular matrix, particularly those characterized by chronic inflammation such as rheumatoid arthritis, atherosclerosis, osteoarthritis and chronic obstructive lung disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18962898      PMCID: PMC2760063          DOI: 10.1016/j.molimm.2008.09.018

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  45 in total

Review 1.  Complement. Second of two parts.

Authors:  M J Walport
Journal:  N Engl J Med       Date:  2001-04-12       Impact factor: 91.245

Review 2.  Complement. First of two parts.

Authors:  M J Walport
Journal:  N Engl J Med       Date:  2001-04-05       Impact factor: 91.245

Review 3.  Collagen binding proteins.

Authors:  L Svensson; A Oldberg; D Heinegård
Journal:  Osteoarthritis Cartilage       Date:  2001       Impact factor: 6.576

Review 4.  Structure and activation of the C1 complex of complement: unraveling the puzzle.

Authors:  Christine Gaboriaud; Nicole M Thielens; Lynn A Gregory; Véronique Rossi; Juan C Fontecilla-Camps; Gérard J Arlaud
Journal:  Trends Immunol       Date:  2004-07       Impact factor: 16.687

5.  Association of chondroadherin with collagen type II.

Authors:  B Mansson; C Wenglén; M Mörgelin; T Saxne; D Heinegård
Journal:  J Biol Chem       Date:  2001-07-09       Impact factor: 5.157

6.  CCP1-4 of the C4b-binding protein alpha-chain are required for factor I mediated cleavage of complement factor C3b.

Authors:  Anna M Blom; Lena Kask; Björn Dahlbäck
Journal:  Mol Immunol       Date:  2003-01       Impact factor: 4.407

7.  Tissue distribution of a novel cell binding protein, osteoadherin, in the rat.

Authors:  Z Shen; S Gantcheva; Y Sommarin; D Heinegård
Journal:  Matrix Biol       Date:  1999-12       Impact factor: 11.583

8.  Identification of tyrosine sulfation in extracellular leucine-rich repeat proteins using mass spectrometry.

Authors:  Patrik Onnerfjord; Terrence F Heathfield; Dick Heinegård
Journal:  J Biol Chem       Date:  2003-10-08       Impact factor: 5.157

9.  Mutations in alpha-chain of C4BP that selectively affect its factor I cofactor function.

Authors:  Anna M Blom; Bruno O Villoutreix; Björn Dahlbäck
Journal:  J Biol Chem       Date:  2003-07-31       Impact factor: 5.157

Review 10.  Rheumatoid arthritis and the complement system.

Authors:  Marcin Okroj; Dick Heinegård; Rikard Holmdahl; Anna M Blom
Journal:  Ann Med       Date:  2007       Impact factor: 4.709

View more
  60 in total

1.  Regulation of complement by cartilage oligomeric matrix protein allows for a novel molecular diagnostic principle in rheumatoid arthritis.

Authors:  Kaisa E Happonen; Tore Saxne; Anders Aspberg; Matthias Mörgelin; Dick Heinegård; Anna M Blom
Journal:  Arthritis Rheum       Date:  2010-12

Review 2.  Small leucine-rich proteoglycans orchestrate receptor crosstalk during inflammation.

Authors:  Kristin Moreth; Renato V Iozzo; Liliana Schaefer
Journal:  Cell Cycle       Date:  2012-06-01       Impact factor: 4.534

Review 3.  The different roles of aggrecan interaction domains.

Authors:  Anders Aspberg
Journal:  J Histochem Cytochem       Date:  2012-09-26       Impact factor: 2.479

Review 4.  Extracellular matrix molecules: potential targets in pharmacotherapy.

Authors:  Hannu Järveläinen; Annele Sainio; Markku Koulu; Thomas N Wight; Risto Penttinen
Journal:  Pharmacol Rev       Date:  2009-06       Impact factor: 25.468

Review 5.  Fell-Muir Lecture: Proteoglycans and more--from molecules to biology.

Authors:  Dick Heinegård
Journal:  Int J Exp Pathol       Date:  2009-12       Impact factor: 1.925

Review 6.  Novel insights into the function and dynamics of extracellular matrix in liver fibrosis.

Authors:  Morten A Karsdal; Tina Manon-Jensen; Federica Genovese; Jacob H Kristensen; Mette J Nielsen; Jannie Marie B Sand; Niels-Ulrik B Hansen; Anne-Christine Bay-Jensen; Cecilie L Bager; Aleksander Krag; Andy Blanchard; Henrik Krarup; Diana J Leeming; Detlef Schuppan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-03-12       Impact factor: 4.052

Review 7.  Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure.

Authors:  Morten A Karsdal; Mette J Nielsen; Jannie M Sand; Kim Henriksen; Federica Genovese; Anne-Christine Bay-Jensen; Victoria Smith; Joanne I Adamkewicz; Claus Christiansen; Diana J Leeming
Journal:  Assay Drug Dev Technol       Date:  2012-10-09       Impact factor: 1.738

Review 8.  Small leucine-rich repeat proteoglycans in corneal inflammation and wound healing.

Authors:  Jihane Frikeche; George Maiti; Shukti Chakravarti
Journal:  Exp Eye Res       Date:  2016-08-26       Impact factor: 3.467

9.  Annexin-II, DNA, and histones serve as factor H ligands on the surface of apoptotic cells.

Authors:  Jonatan Leffler; Andrew P Herbert; Eva Norström; Christoph Q Schmidt; Paul N Barlow; Anna M Blom; Myriam Martin
Journal:  J Biol Chem       Date:  2009-12-01       Impact factor: 5.157

10.  The matricellular functions of small leucine-rich proteoglycans (SLRPs).

Authors:  Rosetta Merline; Roland M Schaefer; Liliana Schaefer
Journal:  J Cell Commun Signal       Date:  2009-10-02       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.